Cefadroxil

   
Google
 
Web NewDrugInformation.com

Cefadroxil


Drug - Cefadroxil
The trade name of the product as shown on the labeling.

Dosage - FOR SUSPENSION; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Cefadroxil/cefadroxil Hemihydrate
Multiple ingredients are in alphabetical order.

Strength - EQ 500MG BASE/5ML
The potency of the active ingredient(s), Cefadroxil/cefadroxil Hemihydrate. May repeat for multiple part products.

Applicant - TEVA
The firm name holding legal responsibility for Cefadroxil. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 062698
The FDA assigned number to Cefadroxil. Format is nnnnnn.

Product Number - 003
The FDA assigned number to identify Cefadroxil. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Mar 1, 1989
The date Cefadroxil was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Cefadroxil. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Cefadroxil is in. Format is RX, OTC, DISCN.

Applicant Full Name - Teva Pharmaceuticals Usa Inc
The full name of the firm holding legal responsibility for the new application of Cefadroxil.

Cefadroxil